Zimmer Biomet Holdings, Inc.
ZBH Healthcare Medical Devices
Zimmer Biomet Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.2 billion, up 7.20% from fiscal 2024. In the quarter to June 2026, revenue grew 4.80%, EPS grew 33.8%, free cash flow grew 13.1% and total debt fell 1.23%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five.
Follow ZBH
Zimmer Biomet Holdings, Inc. (ZBH) Revenue
Zimmer Biomet Holdings, Inc.'s revenue for fiscal 2025 was $8.2B, up 7.20% from $7.7B in fiscal 2024. Over the twelve months to 30 June 2026 it was $8.5B. Over the past ten years it has ranged from $6.0B (fiscal 2015) to $8.2B (fiscal 2025) — the current reading is the highest in ten years. Revenue has risen for 5 consecutive fiscal years. Zimmer Biomet Holdings, Inc. ranks 8th of 140 Medical Devices companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $8.2B | 7.20% |
| FY2024 | $7.7B | 3.85% |
| FY2023 | $7.4B | 6.55% |
| FY2022 | $6.9B | 1.65% |
| FY2021 | $6.8B | 11.42% |
| FY2020 | $6.1B | (23.24%) |
| FY2019 | $8.0B | 0.62% |
| FY2018 | $7.9B | 1.66% |
| FY2017 | $7.8B | 1.76% |
| FY2016 | $7.7B | 27.85% |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Jun 2026 | $2.2B | 4.33% |
| Mar 2026 | $2.1B | (7.00%) |
| Dec 2025 | $2.2B | 12.11% |
| Sep 2025 | $2.0B | (3.65%) |
| 42 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| GEHC GE HealthCare Technologies Inc. compare | $21.3B |
| PHG Koninklijke Philips N.V. compare | $20.6B |
| SNN Smith & Nephew SNATS, Inc. compare | $10.5B |
| ZBH Zimmer Biomet Holdings, Inc. | $8.5B |
| STE STERIS plc compare | $6.0B |
| DXCM DexCom, Inc. compare | $5.0B |
| GMED Globus Medical, Inc. compare | $3.1B |
| BIO.B Bio-Rad Laboratories, Inc. compare | $2.6B |
| PEN Penumbra, Inc. compare | $1.5B |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on ZBH
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement